Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Krsnaa Diagnostics Ltd

₹ 7520.68%
06 Jan – close price
🔗krsnaadiagnostics.com•BSE: 543328•NSE: KRSNAA
Market Cap₹ 2,440 Cr.
Current Price₹ 752
High / Low₹ 939
Stock P/E28.5
Book Value₹ 287
Dividend Yield0.37 %
ROCE12.5 %
ROE9.29 %
Face Value₹ 5.00
Sales₹ 698 Cr.
OPM30.0 %
Mar Cap₹ 2,440 Cr.

ABOUT

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]

KEY POINTS

Business Profile[1]Krsnaa Diagnostics Limited is one of India’s largestdifferentiated diagnostic service providerswith a Pan-India presence in Radiology and Pathology. It has established a Pan India presence through partnerships with government hospitals and operates a substantial number of CT and MRI centers.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsRevenue GuidanceAsset Base ExpansionCapacity Expansion And ProductsPreferential IssuanceOrder Book PositionLarge Order ReceiptsJv Partnerships AcquisitionsRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Dr Lal Pathlabs1479.3046.3924785.820.81152.2016.41730.6010.6628.882599.7028.44534.30150.4010.3819.110.07
2.Vijaya Diagnost.1048.7070.6810772.760.1943.282.75201.5610.1720.91731.8339.81152.4243.2812.4512.290.42
3.Metropolis Healt2029.8066.4810518.830.2052.8913.22429.1922.7014.661483.3122.40158.2352.677.348.240.14
4.Thyrocare Tech.468.4558.377455.931.4947.8179.94216.5322.0924.78762.6429.86127.7347.9913.9412.860.05
5.Nephrocare Health Services492.5574.304942.280.0014.23–473.50–14.11755.8122.0566.5214.23–7.390.36
6.Krsnaa Diagnost.752.1028.542439.710.3723.245.78182.882.3312.52698.3129.9785.4723.242.626.460.30
7.Suraksha Diagno.270.8044.171410.350.008.83-13.0678.7317.9517.84275.9230.9131.938.996.129.830.51
–Median: 13 Co.492.5536.361410.350.018.1513.22192.2216.324.78698.3129.8649.117.76.1212.860.14

Quarterly Results

Standalone figures in ₹ crores

Dec 2022Dec 2023Dec 2024Jun 2023Jun 2024Jun 2025Mar 2023Mar 2024Mar 2025Sep 2022Sep 2023Sep 2024Sep 2025
Sales
116152165132163176116159175121147179183
Expenses
821131171001201269111612187116126125
Operating Profit
34384832435025435334315258
Other Income
5494746444454
Profit before tax
22172819242614222924142831
Tax %
24%20%24%18%23%26%17%17%28%24%20%23%24%
Net Profit
17142215182012182118112223
EPS in Rs
5.374.216.694.865.636.033.765.706.535.723.606.807.16

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
3657108147258396455464590682698
Expenses
354216987373302320340444485489
Operating Profit
015-6260-11494135124146197209
Other Income
3432132651519172622
Interest
668162526188162527
Depreciation
510182632374154758889
Profit before tax
-72-8421-158295908272110115
Net Profit
-82-6012-1121857164598385
EPS in Rs
-15.054.01-116.5424.15-216.83284.7322.5220.2318.1425.6526.41
Dividend Payout %
0%0%0%0%0%0%11%14%14%11%–

Compounded Profit Growth

10 Years:%
5 Years:22%
3 Years:4%
TTM:18%

Compounded Sales Growth

10 Years:%
5 Years:21%
3 Years:14%
TTM:7%

Return on Equity

10 Years:%
5 Years:%
3 Years:9%
Last Year:9%

Stock Price CAGR

10 Years:%
5 Years:%
3 Years:19%
1 Year:-18%

Balance Sheet

Standalone figures in ₹ crores

Mar 2016Mar 2017Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
555561616161616
Reserves
4643-217-17671727799877916
Borrowings
1311023302464744132160202284
Other Liabilities
2463115596146149134197188287
Total Liabilities
1631764936306098779091,1721,2831,503
Fixed Assets
59116223275309386471647668680
Gross Block
71.69139.15287.16307.51376.51491.35626.62873.65967.90–
Accumulated Depreciation
13.1523.0264.1532.4168.00105.66155.94226.49300.22–
CWIP
2064294282510330
Investments
000000003232
Other Assets
8553228345297463413514581761
Total Assets
1631764936306098779091,1721,2831,503

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
–59–6138119129752489
Cash from Investing Activity
–-53–-201-77-67-241-109-129-102
Cash from Financing Activity
–-37–145620176-338414
Net Cash Flow
–-31–4-337164-66-201

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
8791–14087694859110152
Inventory Days
2124–89––––––
Days Payable
7699–878––––––
Cash Conversion Cycle
3215–-65087694859110152
Working Capital Days
-428-119–-234-133-82-2116-1828
ROCE %
–7%––-65%129%18%12%10%13%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
27.79%27.79%27.79%27.79%27.03%27.03%27.17%27.17%27.24%27.24%27.11%27.11%
FIIs
4.14%3.39%5.69%3.68%3.44%3.34%3.33%3.63%4.04%3.55%3.40%3.66%
DIIs
19.41%18.49%19.77%18.73%16.59%15.37%15.26%15.86%14.46%14.26%14.24%14.96%
Public
48.65%50.33%46.74%49.79%52.94%54.27%54.23%53.34%54.27%54.94%55.25%54.27%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Krsnaa Diagnostics Board Strengthened with New Appointments and Committee Reconstitution

17th April 2026, 10:19 pm

Krsnaa Diagnostics Appoints New Directors, Interim CFO, and Reconstitutes Board Committees

17th April 2026, 10:27 pm

Krsnaa Diagnostics Shareholders Approve Re-appointment of Executive Chairman

17th April 2026, 2:14 am

Krsnaa Diagnostics: Shareholder Approval Secured for Re-appointment of Executive Chairman

17th April 2026, 2:11 am

Safety Controls & Devices IPO Allotment Complete; Trading Set to Begin April 13

11th April 2026, 3:36 pm

Published by Other Websites

External media mentions & references

Indian Diagnostics Sector Surges on Home Demand, Faces Margin Pressure

12th April 2026, 10:18 pm

Radiology Fuels Diagnostics Boom: ₹62,000 Cr Market Sees Top Players Emerge

1st April 2026, 5:35 am

Indian Markets Slip Second Day; Infosys Misses Profit Despite Guidance

16th January 2026, 6:59 am

Krsnaa Diagnostics Unveils Bold Growth Strategy: Record Margins & New Projects Set to Skyrocket Future Earnings!

4th December 2025, 10:52 am

Krsnaa Diagnostics Q2 Stellar Show: Rajasthan Mega-Project & B2C Surge Signal HUGE Growth Ahead!

4th December 2025, 10:31 am

News Articles

Editorial & research coverage

Indian Markets Slip Second Day; Infosys Misses Profit Despite Guidance
Indian Markets Slip Second Day; Infosys Misses Profit Despite Guidance

16th January 2026, 6:59 am

Krsnaa Diagnostics Q2 Stellar Show: Rajasthan Mega-Project & B2C Surge Signal HUGE Growth Ahead!
Krsnaa Diagnostics Q2 Stellar Show: Rajasthan Mega-Project & B2C Surge Signal HUGE Growth Ahead!

4th December 2025, 10:31 am

Q2 Earnings Fury: Graphite India & Epigral Crash, Krsnaa Diagnostics Skyrockets! See the Shocking Numbers!
Q2 Earnings Fury: Graphite India & Epigral Crash, Krsnaa Diagnostics Skyrockets! See the Shocking Numbers!

10th November 2025, 5:06 pm

Krsnaa Diagnostics Recovers ₹130 Cr Govt Dues, Posts 4% Revenue Rise
Krsnaa Diagnostics Recovers ₹130 Cr Govt Dues, Posts 4% Revenue Rise

Documents

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

12h - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

2 Jan - -Analyst / Institutional Investor Meeting scheduled to be held on September 05, 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Closure of Trading Window
Board Meeting Outcome for For Meeting Held On December 12, 2025.

12 Dec - Board approved private placement of up to INR 430 crore secured NCDs, 7-year tenor, redemption in 13 instalments.

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2022

(from nse)

Credit Ratings

Rating update

9 Apr 2025 from icra

Rating update

12 Apr 2024 from icra

Rating update

29 Feb 2024 from icra

Rating update

2 Jan 2023 from icra

Rating update

10 Aug 2022 from icra

Rating update

15 Feb 2022 from crisil

Concalls

Nov 2025

TranscriptPPTRecording

Nov 2025

PPT

Aug 2025

TranscriptPPT

May 2025

TranscriptPPT

Feb 2025

TranscriptPPT

Nov 2024

TranscriptPPT

Oct 2024

PPT

Aug 2024

TranscriptPPT

Aug 2024

PPT

May 2024

TranscriptPPTRecording

Feb 2024

TranscriptPPT

Nov 2023

TranscriptPPT

Aug 2023

TranscriptPPT

Jun 2023

TranscriptPPT

Feb 2023

TranscriptPPT

Nov 2022

TranscriptPPT

Aug 2022

TranscriptPPTRecording

Jun 2022

TranscriptPPT

Mar 2022

PPT

Feb 2022

TranscriptPPT

Nov 2021

Transcript

Oct 2021

TranscriptPPT

Stock Analysis

Description

  1. Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.

Key Growth Triggers

  1. Currently no data available for Key Growth Triggers.

Order Book

  1. Currently no data available for Order Book.

Key Red Flags

  1. The resignation of the Chief Financial Officer (CFO), Mr. Pawan Daga, citing personal and professional priorities, is a key event that may warrant investor attention regarding leadership continuity and succession planning.

Key Dates To Watch

  1. Mr. Pawan Daga's last working day is January 19, 2026.

Corporate Announcements

17th Apr 26
Impact Rating: 6
Krsnaa Diagnostics' board has approved the appointment of new directors and reconstitution of committees, effective April 25, 2026, aiming to enhance leadership and governance.
17th Apr 26
Impact Rating: 6
Krsnaa Diagnostics' board appointed Mr. Raju Venkatraman & Ms. Lilian Jessie Paul as Additional Directors (Independent) until April 2028, and Mr. Chetan Desai was re-appointed for 5 years. Mr. Chandra Prakash Singh appointed Interim CFO.
16th Apr 26
Impact Rating: 6
Krsnaa Diagnostics announced that its shareholders have approved the re-appointment of Mr. Rajendra Khivraj Mutha as Executive Chairman for a five-year term. The resolution received strong support via postal ballot voting.
16th Apr 26
Impact Rating: 7
Krsnaa Diagnostics reported that shareholders have passed the ordinary resolution for the re-appointment of Mr. Rajendra Khivraj Mutha as a whole-time director and Executive Chairman for five consecutive years, with voting concluding on April 16, 2026.
11th Apr 26
Impact Rating: 7
Safety Controls & Devices IPO allotment finalized with 15.84 lakh shares at ₹80 for anchor investors. The company expects to begin trading on April 13, 2026, after receiving BSE approval, marking its public debut.